NeuBase Therapeutics (NBSE) Earnings Date, Estimates & Call Transcripts

$0.43
+0.01 (+3.09%)
(As of 11:15 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

NBSE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBSE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NBSE Earnings Date and Information

NeuBase Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

NeuBase Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
11/9/2023Q3 2023($1.82)($0.95)+$0.87($1.24)--
8/14/2023Q3 2023($1.80)($1.26)+$0.54($0.48)--
5/11/2023Q2 2023($2.00)($2.40)($0.40)($0.12)--
2/14/2023Q1 2023($2.20)($2.60)($0.40)($0.13)--
12/21/2022Q4 2022($5.40)($4.80)+$0.60($0.24)--
8/11/2022Q3 2022($6.00)($5.20)+$0.80($0.26)--
5/12/2022Q2 2022($5.20)($6.00)($0.80)($0.30)--
2/10/2022Q1 2022($5.00)($4.80)+$0.20($0.24)--    
12/23/2021Q4($4.60)($4.20)+$0.40($0.21)--
8/12/2021Q3 2021($4.80)($5.80)($1.00)($0.29)--
5/13/2021Q2 2021($4.60)($4.80)($0.20)($0.24)--

NeuBase Therapeutics Earnings - Frequently Asked Questions

When is NeuBase Therapeutics's earnings date?

NeuBase Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on NBSE's earnings history.

How much profit does NeuBase Therapeutics generate each year?

NeuBase Therapeutics (NASDAQ:NBSE) has a recorded net income of -$4.37 million. NBSE has generated -$7.70 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:NBSE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners